Katz Diagnostics, Inc.

Katz Diagnostics, Inc., founded by renowned rheumatologist Dr. Robert Katz, is developing a biomarker-based test to definitively diagnose fibromyalgia syndrome (FMS). This prevalent disease affects primarily women and is often misdiagnosed, leading to years of pain and expensive testing. A device that diagnoses and monitors the disease can lead to better, non-opioid management and even a cure someday. The company is raising money to develop a prototype for clinical trials to begin in early 2024.

• Employees 1
• Founded 2019